V
48
-22
HPE
42
-11
UNM
62
-8
VFC
54
-7
TXT
42
-7
FRT
31
-12
AXP
60
-7
CMA
39
-4
HSY
31
-6
AKAM
48
-5
MCO
64
-7
JBHT
43
-7
SRE
26
-12
NSC
30
-4
JNPR
56
-6
PPG
54
-4
EXC
48
-3
HPQ
49
-4
PRGO
28
-4
TSN
20
-3
V
48
-22
HPE
42
-11
UNM
62
-8
VFC
54
-7
TXT
42
-7
FRT
31
-12
AXP
60
-7
CMA
39
-4
HSY
31
-6
AKAM
48
-5
MCO
64
-7
JBHT
43
-7
SRE
26
-12
NSC
30
-4
JNPR
56
-6
PPG
54
-4
EXC
48
-3
HPQ
49
-4
PRGO
28
-4
TSN
20
-3
Financhill
Back

Daxor Quote, Financials, Valuation and Earnings

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
23

DXR
Daxor

Last Price:
8.14
Seasonality Move:
11.73%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Daxor Price Quote

$8.14
-0.06 (-0.73%)
(Updated: December 19, 2024 at 5:56 PM ET)

Daxor Key Stats

Sell
23
Daxor (DXR) is a Sell
Day range:
$8.06 - $8.38
52-week range:
$7.19 - $10.04
Dividend yield:
0%
P/E ratio:
58.00
P/S ratio:
15.02
P/B ratio:
1.2%
Volume:
3.1K
Avg. volume:
28.3K
1-year change:
-1.93%
Market cap:
$39.3M
Revenue:
$1.3M
EPS:
$0.3

How Much Does Daxor Make?

  • How Much Are Daxor's Sales Annually?
    DXR Revenues are $1.3M
  • How Much Profit Does Daxor's Make A Year?
    DXR net income is $280.6K

Is Daxor Growing As A Company?

Data Unavailable

Daxor Stock Price Performance

  • Did Daxor Stock Go Up Last Month?
    Daxor share price went down by -7.93% last month
  • Did DXR's Share Price Rise Over The Last Year?
    DXR share price fell by -1.93% over the past 1 year

What Is Daxor 52-Week High & Low?

  • What Is Daxor’s 52-Week High Share Price?
    Daxor has traded as high as $10.04 over the past 52 weeks
  • What Is Daxor’s 52-Week Low Share Price?
    Daxor has traded as low as $7.19 over the past 52 weeks

Daxor Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Daxor?

Data Unavailable

Is Daxor Cash Flow Positive?

Data Unavailable

Daxor Return On Invested Capital

  • Is Management Doing A Good Job?
    DXR return on invested capital is 5.09%
  • What Is Daxor Return On Assets?
    ROA measures how assets are converting to revenues and is 5.08%
  • What Is DXR Return On Equity?
    ROE is a measure of profitability and is 5.22%

Daxor Earnings Date & Stock Price

  • What Is Daxor's Stock Price Today?
    A single share of DXR can be purchased today for 8.20
  • What Is Daxor’s Stock Symbol?
    Daxor trades on the nasdaq under the ticker symbol: DXR
  • When Is Daxor’s Next Earnings Date?
    The next quarterly earnings date for Daxor is scheduled on March 25, 2025
  • When Is DXR's next ex-dividend date?
    Daxor's next ex-dividend date is January 5, 2018
  • How To Buy Daxor Stock?
    You can buy Daxor shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Daxor Competitors

  • Who Are Daxor's Competitors?
    Below is a list of companies who compete with Daxor or are related in some way:
    • AptarGroup Inc (ATR)
    • Perspective Therapeutics Inc (CATX)
    • Precision Optics Corp Inc (POCI)
    • Sanara MedTech Inc (SMTI)
    • Warby Parker Inc (WRBY)

Daxor Dividend Yield

  • What Is DXR Dividend Yield?
    Daxor’s dividend yield currently is 0%
  • What Is Daxor’s Payout Ratio?
    Daxor’s payout ratio is 0%
  • When Did Daxor Last Pay A Dividend?
    The latest dividend pay date is December 19, 2024
  • What Is Daxor’s Dividend Per Share?
    Daxor pays a dividend of $0.00 per share

Daxor Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 23.38
Upside from Last Price: 185.06%

Major Shareholders

  • How many DXR shares are owned by institutional investors?
    144.4K DXR shares are owned by institutional investors
  • How many DXR shares are owned by insiders?
    3.1M DXR shares are owned by insiders